商晶晶简介

一、个人情况介绍

商晶晶，女，1988年3月，药理学硕士，副主任药师，硕士研究生导师，抗凝专业临床药师。长期从事骨科临床药学工作，在预防血栓、抗感染及营养等方面有丰富的临床实践经验。

目前主要研究方向：1）临床药学及药事管理；2）干细胞诱导分化成成骨或破骨细胞相关因素研究

二、代表性成果（包括文章，课题等）

主持中华国际医学交流基金会中华临床药学专项基金1项，全国静脉血栓防治专项基金1项，其他省市级课题8项。近年来以第一/通讯作者发表论文9篇，其中SCI论文8篇。

近五年以第一或通讯作者发表的主要期刊论文：

1. JingJing Shang, Zhentang Yu, Chengwei Xiong, Junjie Zhang, Jinhong Gong, Changlin Yu, Yong Huang, Xindie Zhou*. Resistin targets TAZ to promote osteogenic differentiation through PI3K/AKT/mTOR pathway. ISCIENCE. 2023.

2. Jingjing Shang, Shijie Jiang, Jinhong Gong, Gongyin Zhao, Dan Su, Liangliang Wang*. Low albumin-to-fibrinogen ratio predicts adverse clinical outcomes after primary total joint arthroplasty: A retrospective observational investigation. Int Wound J. 2023 May 31. doi: 10.1111/iwj.14260. Epub ahead of print.

3. Jingjing Shang, Gongyin Zhao, Jinhong Gong, Dan Su, Yuji Wang, Liangliang Wang*. Nutritional Risk Screening 2002 predicts surgical outcomes in 1532 patients undergoing total joint arthroplasty: a retrospective cohort study. Nutr Clin Pract. 2023 Jun;38(3):636-647.

4. Xindie Zhou, Jinhong Gong, Dan Su, Zijuan Wu, Xiaojun Jia, Yuji Wang, Nanwei Xu, Jingjing Shang*. Effect of pharmacist intervention on antibiotic prophylaxis in orthopedic internal fixation: A retrospective study.Res Social Adm Pharm. 2023 Feb;19(2):301-307.

5. Jingjing Shang*, Liangliang Wang, Jinhong Gong, Dan Su, Xiaojun Jia, Yuji Wang*. Impact of antibiotic prophylaxis courses on postoperative complications following total joint arthroplasty_ Finding from Chinese population. J Clin Pharm Ther. 2022 Jan;47(1):61-69.

6. Zijuan Wu, Jinhong Gong, Xiaomei He, Zhouquan Wu, Jingjing Shen, Jingjing Shang*. Body mass index and pharmacodynamics of target-controlled infusion of propofol: A prospective non-randomized controlled study. J Clin Pharm Ther. 2022;00:1-6.

7. Jingjing Shang*, Wei Ning, Jinhong Gong, Dan Su, Xiaojun Jia, Yuji Wang*. Impact of clinical pharmacist services on anticoagulation management of total joint arthroplasty: A retrospective observational study. J Clin Pharm Ther. 2021 Oct;46(5):1301-1307.

三、联系方式

Email：shang0308@126.com